News & Blog
Updates every week
-
Nagi Bioscience passed Venture Kick stage 1
29/03/18 – News Article
Great news: Nagi Bioscience passed stage 1 of Venture Kick! On the way for stage 2 now! Venture Kick was launched in 2007 with the vision to double the number of spin-offs at Swiss universities, to…
-
Nagi Bioscience listed in Bilan’s TOP 50 Swiss start-up companies!
28/02/18 – News Article
We are glad and very proud to be among the TOP50 start-up in which to invest in 2018 selected by the prestigious swiss economic newspaper Bilan. Every year, the magazine Bilan selects 50 of…
-
We are in the news!
02/11/17 – News Article
Nagi Bioscience is featured today in the Swiss newspaper Le Temps. This article (in French) discusses the current problematic of animal testing in the scientific research and highlight the solution developed by Nagi…
-
Nagi Bioscience at the Hello Tomorrow Summit in Paris
25/10/17 – News Article
From tomorrow morning till Friday evening, Nagi Bioscience will attend the Hello Tomorrow Summit in Paris as one of the World’s TOP500 Deep-Tech Startups. We are glad to be one of the startups selected…
-
Our technology will be presented at ILMAC Lausanne 2017
19/09/17 – News Article
We are delighted to announce that our team will pitch the technology developed by Nagi Bioscience during the ILMAC Lausanne exhibition on Thursday, the 5th of October. The first-ever edition of ILMAC LAUSANNE is taking…
-
Nagi Bioscience results presented at Eurotox 2017 conference in Bratislava
14/09/17 – News Article
From September 10th to 13th, Nagi Bioscience attended the 53rd Congress of the European Societies of Toxicology (EuroTox) in Bratislava. Our team presented for the first time a poster with the latest results obtained in…
-
We made it to the top 500 in the Hello Tomorrow Global Challenge!
14/07/17 – News Article
We are delighted to announce that Nagi Bioscience has been chosen by Hello Tomorrow as one of the world’s TOP 500 deep-tech startups! Hello Tomorrow is a global not-for-profit organization created by deep tech entrepreneurs, with…
-
A collaborative study between the University of Melbourne (Prof. Gasser’s Lab) and the Nagi Bioscience team was published today
10/07/17 – News Article
We are happy to announce the release of a new publication in collaboration with the Laboratory of Prof. Robin Gasser from the University of Melbourne. The article issued today in the FASEB Journal shows that deguelin, a plant-derived rotenoid,…
-
The platform developed by Nagi Bioscience is featured on the website of the Swiss Laboratory Animal Association (SGV)
23/06/17 – News Article
In 2015, the project developed by Nagi Bioscience was the first recipient of the SGV 25th Fund. This fund was created by the SGV board to financially support projects related to the goals of the…
-
Nagi Bioscience ranked TOP 10 at “Venture.ch” business plan competition
22/06/17 – News Article
Our Business Plan was awarded as TOP 10, among 108 submitted projects! »Venture» is Switzerland’s premier startup competition, initiative of ETH Zurich, EPF Lausanne, Knecht Holding, the innovation promotion agency CTI and McKinsey &…
-
Nagi Bioscience wins the Egon Naef Award 2017
25/03/17 – News Article
This prestigious prize is given annually by the “E. Naef Foundation for in vitro research” (FENRIV), established in 1998. The foundation assists researchers investigating scientific means for restricting the use of vivisection and generally…
-
Nagi Bioscience receives financial support from the Gebert Rüf Stiftung
04/11/16 – News Article
Gebert Rüf Stiftung fosters innovations for the benefit of Swiss economy and society, by supporting application-oriented and impact-oriented scientific projects at Swiss universities. The “Nematrix Project”, by Nagi Bioscience, became part of the…
Let’s connect
Keen to hear about the latest news in the world of alternative testing methods? Are you interested in learning about the latest techniques in toxicology? Maybe a worm enthusiast?
Blog post, #ResearchAlerts, webinars, trending news, and much more in the Nagi Social Channels
Follow us
